SSAA09E2 是一种新型的SARS-CoV复制抑制剂，通过阻断SARS-S与SARS-CoV受体血管紧张素转换酶-2 的早期相互作用发挥作用。

SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).

883944-52-3

C16H20N4O2

300.362

DMSO:230 mg/mL (765.75 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years